CBC-backed Jadeite Medicines Announces Exclusive Licensing Agr...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
TOKYO, Oct. 12, 2021 /PRNewswire-AsiaNet/ -- - Agreement to accelerate the development and commercialization of odevixibat in Japan, a significant market for PFIC, Alagille syndrome and biliary atresia - Bylvay™ (odevixibat) approved in U.S., EU and UK with global prescriptions already gen...
Authors: LATEST ASIANET NEWS RELEASES